[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) · Source last updated 2020-10-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
NUMBER
Unit
mGy/MBq
Interval / dispersion
Not reported
Time frame
[68Ga]-NeoBOMB1 PET imaging acquired at Day 1
What was measured
The absorbed dose in target organs and the effective radiation dose were to be summarized with descriptive statistics. Lesion number were assigned by dosimetry expert.
Analysis population: Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. Due to the sample size in the dosimetry group (2 patients), summary statistics were not performed.
Groups in this outcome
Breast
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Breast
2
Reported measurements
Participant 1-Alveolar interstital (Lungs)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0359
Not reported
Not reported
Not reported
Not reported
Participant 1-Bone Marrow
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0118
Not reported
Not reported
Not reported
Not reported
Participant 1-Heart
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0361
Not reported
Not reported
Not reported
Not reported
Participant 1-Kidneys
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0467
Not reported
Not reported
Not reported
Not reported
Participant 1-Liver
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0670
Not reported
Not reported
Not reported
Not reported
Participant 1-Pancreas
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.3620
Not reported
Not reported
Not reported
Not reported
Participant 1-Spleen
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0221
Not reported
Not reported
Not reported
Not reported
Participant 1-Urinary bladder wall
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0683
Not reported
Not reported
Not reported
Not reported
Participant 2-Alveolar interstital (Lungs)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0241
Not reported
Not reported
Not reported
Not reported
Participant 2-Bone Marrow
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0064
Not reported
Not reported
Not reported
Not reported
Participant 2-Heart
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0158
Not reported
Not reported
Not reported
Not reported
Participant 2-Kidneys
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0339
Not reported
Not reported
Not reported
Not reported
Participant 2-Liver
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0450
Not reported
Not reported
Not reported
Not reported
Participant 2-Pancreas
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.2270
Not reported
Not reported
Not reported
Not reported
Participant 2-Spleen
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.0189
Not reported
Not reported
Not reported
Not reported
Participant 2-Urinary bladder wall
Analysis denominator · Participants
Group
Source count
Breast
1
Values in mGy/MBq · Interval/dispersion: Not reported
Group
Value
Spread
Lower
Upper
Comment
Breast
0.1010
Not reported
Not reported
Not reported
Not reported
Complete source fields
classes
categories
measurements
group Id
OG000
value
0.0359
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Alveolar interstital (Lungs)
categories
measurements
group Id
OG000
value
0.0118
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Bone Marrow
categories
measurements
group Id
OG000
value
0.0361
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Heart
categories
measurements
group Id
OG000
value
0.0467
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Kidneys
categories
measurements
group Id
OG000
value
0.0670
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Liver
categories
measurements
group Id
OG000
value
0.3620
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Pancreas
categories
measurements
group Id
OG000
value
0.0221
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Spleen
categories
measurements
group Id
OG000
value
0.0683
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 1-Urinary bladder wall
categories
measurements
group Id
OG000
value
0.0241
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 2-Alveolar interstital (Lungs)
categories
measurements
group Id
OG000
value
0.0064
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 2-Bone Marrow
categories
measurements
group Id
OG000
value
0.0158
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 2-Heart
categories
measurements
group Id
OG000
value
0.0339
denoms
counts
group Id
OG000
value
1
units
Participants
title
Participant 2-Kidneys
denoms
counts
group Id
OG000
value
2
units
Participants
description
The absorbed dose in target organs and the effective radiation dose were to be summarized with descriptive statistics. Lesion number were assigned by dosimetry expert.
groups
description
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
id
OG000
title
Breast
param Type
NUMBER
population Description
Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. Due to the sample size in the dosimetry group (2 patients), summary statistics were not performed.